Company Analysis

Hyperion DeFi, Inc. (HYPD)

Nasdaq: HYPD · Pharmaceutical Preparations · New York, NY · filing with the SEC since 2016
Grade3.0
◀ Past 2.3● Present 1.9▶ Future 4.4
1 est.

Who runs Hyperion DeFi, Inc.

Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filed
Chief executive, as filed
Jung Hyunsu
Chief Executive Officer and Chief Investment Officer. First filing Jun 2025, latest Aug 18, 2026, 1 filing in all.
Officers reporting now
4
of 8 people with a filing in the last fifteen months
Directors reporting now
4
24 people on the record since 2018
Officerssales are open-market, Sep 30, 2025 to Sep 30, 2026
NameTitle as filedFirst filingLatest filingSales, 12 months
Knox David R.Chief Financial OfficerSep 2025Sep 30, 2026none
Jung HyunsuChief Executive Officer and Chief Investment OfficerJun 2025Aug 18, 2026none
Rubenstein RobertGeneral CounselJan 2026Jan 12, 2026none
Rowe Michael MChief Executive OfficerJul 2018Jul 9, 2025none
Directorssales are open-market, Sep 30, 2025 to Sep 30, 2026
NameRoleFirst filingLatest filingSales, 12 months
Geltzeiler Michael SdirectorNov 2023Jul 1, 2026none
Jacobson RacheldirectorMar 2022Jul 1, 2026none
Strahlman Ellen RdirectorJul 2022Jul 1, 2026none
Walters Happy DaviddirectorSep 2025Jul 1, 2026none
Earlier names on the record22, newest filing first

A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.

SI Assistanton HYPD · research, not advice